# US 2021/0332373 A1 · E. coli-based production of beta-lactamase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332373 A1
- Document ID: US20210332373A1
- Status: Published application
- Kind: A1
- Application number: 17/314,583
- Filed: 2021-05-07
- Published: 2021-10-28
- Earliest claimed: 2014-08-28
- Assignees: Synthetic Biologics, Inc.
- Applicants: Synthetic Biologics, Inc.
- Inventors: Andrew BRISTOL; Michael KALEKO; Steven HUBERT
- Web page: https://patentgrep.com/patent/US20210332373A1

## CPC

- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 9/86: acting on amide bonds in cyclic amides, e.g. penicillinase {(3.5.2)}
- C12N 15/67: General methods for enhancing the expression
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12Y 305/02006: Beta-lactamase (3.5.2.6)
- C12N 15/09: Recombinant DNA-technology
- C12N 15/75: for Bacillus
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention relates to, in part, improved methods for the production of beta-lactamase using Escherichia coli (E. coli) cells. High yield production of beta-lactamase is achieved using methods of the invention.

## Claims

### Claim 1

A method for the production of a beta-lactamase polypeptide in Escherichia coli (E. coli), comprising:
(a) providing a host E. coli cell transformed with an expression vector comprising a sequence encoding the beta-lactamase polypeptide;
(b) culturing the E. coli cell to induce expression of the beta-lactamase polypeptide in the cytoplasm; and
(c) recovering the beta-lactamase polypeptide from a cytoplasmic soluble fraction prepared from the E. coli cell; and
wherein the method yields more than 10 grams of the beta-lactamase polypeptide per liter of culture,
wherein the beta-lactamase polypeptide is not recovered or purified from a periplasmic fraction, a cell envelope fraction, a cytoplasmic insoluble fraction, an inclusion body, or an extracellular fraction of the E. coli cell.

### Claim at position 2

2-3. (canceled)

### Claim 4 (depends on 1)

The method of claim 1, wherein the method yields more than 15 grams of the beta-lactamase polypeptide per liter of culture.

### Claim 5 (depends on 1)

The method of claim 1, wherein the E. coli cell is selected from BL21(DE3) or W3110.

### Claim 6 (depends on 1)

The method of claim 1, wherein expression of the beta-lactamase polypeptide in the cytoplasm is induced by adding isopropylthiogalactoside (IPTG) to the culture.

### Claim 7 (depends on 1)

The method of claim 1, wherein the beta-lactamase polypeptide comprises an amino acid sequence having at least 95% identity with SEQ ID NO: 1 (P1A).

### Claim 8 (depends on 1)

The method of claim 1, wherein the beta-lactamase polypeptide comprises an amino acid sequence having at least 95% identity with SEQ ID NO: 10 (P2A).

### Claim 9 (depends on 1)

The method of claim 1, wherein the beta-lactamase polypeptide comprises an amino acid sequence having at least 95% identity with SEQ ID NO: 5 (P3A).

### Claim 10 (depends on 1)

The method of claim 1, wherein the beta-lactamase polypeptide comprises an amino acid sequence having at least 95% identity with SEQ ID NO: 7 (P4A).

### Claim 11

(canceled)

### Claim 12 (depends on 9)

The method of claim 9, wherein the beta-lactamase polypeptide comprises an amino acid sequence of SEQ ID NO: 5 (P3A).

### Claim 13 (depends on 8)

The method of claim 8, wherein the beta-lactamase polypeptide comprises an amino acid sequence of SEQ ID NO: 10 (P2A).

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The method of claim 1, wherein the production comprises the use of an expression vector comprising palindromic DNA looping.

### Claim 16 (depends on 1)

The method of claim 1, wherein the production comprises the use of an expression vector suitable for tightly controlled gene expression.

### Claim 17 (depends on 1)

The method of claim 1, wherein the production comprises a single chromatography column step.

### Claim 18

(canceled)

### Claim 19

A method for the production of a beta-lactamase polypeptide in Escherichia coli (E. coli), comprising:
(a) providing a host E. coli cell transformed with an expression vector comprising a sequence encoding the beta-lactamase polypeptide;
(b) culturing the E. coli cell to induce expression of the beta-lactamase polypeptide in the cytoplasm; and
(c) recovering the beta-lactamase polypeptide from a soluble fraction prepared from the E. coli cell; wherein:
the method yields more than 15 grams of the beta-lactamase polypeptide per liter of culture;
wherein the beta-lactamase polypeptide is not recovered or purified from a periplasmic fraction, a cell envelope fraction, a cytoplasmic insoluble fraction, an inclusion body, or an extracellular fraction of the E. coli cell.
